Kamil Hanna, MD
Clinical Cardiac Electrophysiology · Albany, GANPI 1881632099
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by Medtronic at 45.7% of the total. Reporting peaked in 2023 at $8,056 and has fallen 82.6% since, to $1,400 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in GA, where the typical reported total is $21,716.
Across 353 payments — averaging $61.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Atricure, Inc.$5K
- Boston Scientific$2K
- Abbott$2K
- Elutia, Inc.$889
- E.r. Squibb & Sons, L.L.C.$780
- plus $2K from 16 others
Across 58 payments — averaging $1957.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$106K
- Boston Scientific$8K
What the payments were for
- Travel & lodging$11,49353%
- Food & beverage$10,22347%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 86 | $9,927 |
| Atricure, Inc. | 32 | $4,654 |
| Boston Scientific | 42 | $2,020 |
| Abbott | 17 | $1,622 |
| Elutia, Inc. | 17 | $889 |
| E.r. Squibb & Sons, L.L.C. | 51 | $780 |
| Johnson & Johnson | 37 | $500 |
| Novartis | 20 | $365 |
| Pfizer | 12 | $180 |
| Amgen | 8 | $130 |
| W. L. Gore & Associates, Inc. | 1 | $125 |
| Merck | 7 | $123 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $81 |
| AstraZeneca | 5 | $81 |
| Boehringer Ingelheim | 4 | $79 |
| Cardiva Medical, Inc. | 2 | $37 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
| Biosense Webster, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
| Philips North America LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$2,983
- Arctic Front$1,988
- Micra$1,496
- ATRICLIP LAA EXCLUSION SYSTEM$1,294
- ENSITE PRECISION$747
- ENSITE$582
- SYNERGY ABLATION SYSTEM$327
- ECM Patch,Pouch$178
- SelectSecure$163
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$137
- NA$125
- GORE EXCLUDER AAA Endoprosthesis$125
- WATCHMAN Access System$111
- Reveal LINQ$108
How this compares
$21,716 in reported general payments places this provider in the 50th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 615 | $493,508 |
| XareltoRivaroxaban | 267 | $206,928 |
| EntrestoSacubitril/Valsartan | 67 | $60,706 |
| MounjaroTirzepatide | 30 | $31,170 |
| MultaqDronedarone Hcl | 34 | $29,243 |
| TikosynDofetilide | 13 | $10,101 |
| PradaxaDabigatran Etexilate Mesylate | 32 | $6,300 |
| SavaysaEdoxaban Tosylate | 12 | $5,006 |
| Dofetilide | 47 | $4,565 |
| Flecainide Acetate | 219 | $4,527 |
| Metoprolol Succinate | 268 | $3,213 |
| SotalolSotalol Hcl | 196 | $3,008 |
| Propafenone Hcl | 92 | $2,687 |
| Colchicine | 65 | $2,649 |
| Potassium Chloride | 107 | $2,515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $180 | $493,508615 claims |
| Johnson & JohnsonXarelto | $500 | $206,928267 claims |
| NovartisEntresto | $365 | $60,70667 claims |
| Boehringer IngelheimPradaxa | $79 | $6,30032 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Albany
- Edward KoomsonAlbany$47K
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Alok GambhirGainesville$146K
- Joseph PokuMacon$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.